- Direction
- Improving
- Own history
- —
- Peers
- 91th
- Persistence
- EMERGING
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTGLAUKOS Corp's latest supported as-filed period reports revenue of $211.0M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.99% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 18.28% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 58.03% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 28.92% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 85.23% · CORE
Level · gp.fundamentals.operating_margin
Raw value 0.39% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 58.0%; Operating margin moved 1265 bp higher; Operating income changed across a sign change.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 49.5%; Operating margin moved 898 bp higher; Operating income increased 23.9%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents increased 13.6%; Operating cash flow increased 112.4%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents increased 65.2%; Operating cash flow changed across a sign change.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 132.2%; Capex / revenue moved 53 bp higher.
2 evidence-backed componentsCurrent liabilities changed +44.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
GKOS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-436400SEC ↗8-KOct 28, 2026Period Oct 28, 20260001193125-26-436147SEC ↗4Oct 7, 2026Period Oct 5, 20260001193125-26-417151SEC ↗4Sep 28, 2026Period Sep 25, 20260001920053-26-000030SEC ↗4Sep 18, 2026Period Sep 16, 20260001920053-26-000028SEC ↗4Sep 1, 2026Period Aug 28, 20260001920053-26-000026SEC ↗4Aug 20, 2026Period Aug 19, 20260001293171-26-000012SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Oct 5, 2026Filed Oct 7, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 888 | $164 | $145,570 | Form 4 ↗ |
| Oct 5, 2026Filed Oct 7, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 327 | $165 | $53,883 | Form 4 ↗ |
| Oct 5, 2026Filed Oct 7, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 312 | $166 | $51,667 | Form 4 ↗ |
| Sep 25, 2026Filed Sep 28, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 167 | $152 | $25,334 | Form 4 ↗ |
| Sep 25, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 14.67% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 8.42% · OPTIONAL
Current assets changed +27.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +23.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed +875 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed +949 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +18.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed +67.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001705850-26-000022| Navratil TomasCHIEF DEVELOPMENT OFFICER |
| Open Market SaleDirect |
| 136 |
| $153 |
| $20,769 |
| Form 4 ↗ |
| Sep 25, 2026Filed Sep 28, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 229 | $154 | $35,321 | Form 4 ↗ |
| Sep 25, 2026Filed Sep 28, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 1,083 | $155 | $167,735 | Form 4 ↗ |
| Sep 16, 2026Filed Sep 18, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 103 | $163 | $16,810 | Form 4 ↗ |
| Sep 16, 2026Filed Sep 18, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 345 | $165 | $56,787 | Form 4 ↗ |
| Sep 16, 2026Filed Sep 18, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 191 | $166 | $31,744 | Form 4 ↗ |
| Sep 16, 2026Filed Sep 18, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 460 | $167 | $76,967 | Form 4 ↗ |
| Sep 16, 2026Filed Sep 18, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 120 | $168 | $20,206 | Form 4 ↗ |
| Sep 16, 2026Filed Sep 18, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 234 | $171 | $40,002 | Form 4 ↗ |
| Sep 16, 2026Filed Sep 18, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 4 | $172 | $688 | Form 4 ↗ |
| Aug 28, 2026Filed Sep 1, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 7,643 | $180 | $1.4M | Form 4 ↗ |
| Aug 28, 2026Filed Sep 1, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 6,091 | $181 | $1.1M | Form 4 ↗ |
| Aug 28, 2026Filed Sep 1, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Open Market SaleDirect | 10 | $183 | $1,825 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Kliman Gilbert HDirector | Option ExerciseDirect | 2,500 | $26 | $64,425 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Kliman Gilbert HDirector | Open Market SaleDirect | 2,500 | $190 | $475,000 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Kliman Gilbert HDirector | Option ExerciseDirect | 2,500 | $0 | $0 | Form 4 ↗ |